Endogenous expression of Axl and Gas6 increased in microglia/macrophage after stroke, while intranasal injection of recombinant Gas6 (rGas6) reduced the neurological deficits through inhibiting neuroinflammation by inhibiting TLR/TRAF/NF-kappaB pathway (64). The gene discussed is GAS6; the disease is Stroke.